Palbociclib improves progression-free survival in HER2 positive breast cancer News-MedicalIbrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast Cancer Cure TodayAlliance Foundation Trials phase III PATINA study results published in the New England Journal of Medicine EurekAlert!Palbociclib as adjunct maintenance therapy prolongs progression-free survival in some types of metastatic breast cancer 2 Minute MedicinePaolo Tarantino: PATINA Trial Brings Metastatic Breast Cancer Closer to a Chronic Disease Oncodaily
